DaVita® Medical Insights

Podcast: Collaboration Between Dialysis and Kidney Transplant Teams

Dialysis and transplant teams face challenges that may affect patients on their transplant journey or their abilities to get on waitlists. Listen to this podcast, in which Jill Rankin interviews Chief Medical Officer of DaVita Integrated Care Bryan Becker, MD, and Transplant Surgeon Adam Bingaman, MD, on how communication and collaboration between dialysis, nephrology, and transplant teams are keys to overcome these challenges and provide transplant patients with the best possible care. Drs. Becker and Bingaman also discuss innovation and quality in the transplant space. This discussion is timely with April being National Donate Month.

Bryan Becker, MD, MMM, FACP, CPE

Bryan Becker, MD, MMM, FACP, CPE

Bryan N. Becker, MD, is chief medical officer of DaVita Integrated Care and has nearly 20 years of physician executive experience. He received his AB in English at Dartmouth College and MD from the University of Kansas, and, after training at Duke and Vanderbilt, he led the nephrology group at the University of Wisconsin and developed a new kidney care venture called Wisconsin Dialysis, Inc. He also served as CEO at the University of Illinois Hospital and Clinics and president of the National Kidney Foundation. Before joining DaVita Kidney Care, Dr. Becker served as President of the University of Chicago Medicine (UCM) Care Network, a more than 1,000 physician clinical integration organization, and Vice President, Clinical Integration and Associate Dean, Clinical Affairs at UCM. Twitter: @bnbeckermd

Adam Bingaman, MD, PhD

Adam Bingaman, MD, PhD

Kidney and pancreas transplant surgeon Adam Bingaman, MD, PhD, is the director of abdominal organ transplantation at Methodist Specialty and Transplant Hospital in San Antonio. Dr. Bingaman leads the nation’s largest living donor and paired donor programs in the United States and has lectured at academic institutions around the world, including Cambridge University, Yale University and Mayo Clinic. He has spoken on live donor kidney transplantation and histocompatibility to transplant organizations in Spain, Poland, Belgium, Canada, Latin America and South Korea, and has been published extensively in the field of transplantation immunology. Dr. Bingaman graduated from Cornell University in Ithaca, New York, with a bachelor of arts degree in biochemistry and received his medical degree cum laude from Boston University School of Medicine in Boston. He completed his general surgery residency at Emory University Affiliated Hospitals Residency Program in Atlanta and earned a doctorate in immunology from Emory University Graduate School of Arts and Sciences Division of Immunology and Molecular Pathogenesis. Dr. Bingaman completed his fellowship training in kidney and pancreas transplantation surgery at the University of Maryland School of Medicine in Baltimore.